Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Adaptive Biotechnologies CorpListing on record | Sell | $55.7M | SEC | ||
BridgeBio Pharma, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
BridgeBio Pharma, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
BridgeBio Pharma, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
BridgeBio Pharma, Inc.Listing on record | Buy | $80M | conv 24 | SEC | |
BridgeBio Pharma, Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Myovant Sciences Ltd.Listing unverified | Buy | $20M | conv 37Cluster | SEC | |
Sio Gene Therapies Inc.Listing unverified | Buy | $10M | conv 41ClusterFirst in 12mo | SEC |